Form 4: MaxCyte Executive Receives Stock Options and Restricted Stock Units

David I. Sandoval, General Counsel of MaxCyte, Inc., reports the acquisition of stock options and restricted stock units.

Summary

• On March 14, 2025, David I. Sandoval, General Counsel of MaxCyte, Inc., acquired 92,500 stock options with an exercise price of $3.29.
• These options vest 25% on March 14, 2026, and the remainder in 36 equal monthly installments, contingent on continued service.
• Sandoval also acquired 23,125 restricted stock units (RSUs) at a price of $0.
• These RSUs vest 25% on March 14, 2026, and the remainder in three equal annual installments, also contingent on continued service.
• Following these transactions, Sandoval directly owns 64,572 shares of MaxCyte common stock and 92,500 derivative securities.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, indicating confidence in the company's future performance. The sentiment is neutral to positive.

Positives

• The grant of stock options and RSUs aligns the General Counsel's interests with those of the shareholders.
• The vesting schedules incentivize continued service and commitment to the company's long-term success.

Future Outlook

The vesting of the stock options and RSUs is contingent upon the Reporting Person's continued service to the Issuer through each vesting date.

Industry Context

Stock option and RSU grants are common compensation practices for executives in publicly traded companies, aligning their interests with shareholder value and incentivizing long-term performance.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in the biotechnology industry.
• Companies like CRISPR Therapeutics and Editas Medicine also utilize stock options and RSUs to incentivize their executives.
• The vesting schedules are typical, with vesting periods ranging from three to four years.

Stakeholder Impact

• Shareholders may view the stock option and RSU grants positively, as they align management's interests with the company's long-term success.
• Employees may be motivated by the fact that executives are incentivized to improve company performance.

Key Dates